Report Detail
Global Age Related Macular Degeneration Drug Market Growth 2019-2024
- RnM3040595 |
- 28 February, 2019 |
- Global |
- 139 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Age-related macular degeneration (AMD) is a disease that blurs the sharp, central vision you need for “straight-ahead” activities such as reading, sewing, and driving. AMD affects the macula, the part of the eye that allows you to see fine detail.
Age Related Macular Degeneration Drug is widely used in hospitals, clinics and other field. The most proportion of Age Related Macular Degeneration Drug is used in Hospital, and the proportion in 2017 is 72%.
North America is the largest consumption place, with a consumption market share nearly 65.6% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
According to this study, over the next five years the Age Related Macular Degeneration Drug market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 8670 million by 2024, from US$ 6080 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Age Related Macular Degeneration Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Age Related Macular Degeneration Drug market by product type, application, key manufacturers and key regions and countries.
This study considers the Age Related Macular Degeneration Drug value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Lucentis
Eylea
Avastin
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Clinics
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Regeneron Pharmaceuticals
Bayer HealthCare
Novartis
Roche
Kanghong Pharma
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Age Related Macular Degeneration Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Age Related Macular Degeneration Drug market by identifying its various subsegments.
Focuses on the key global Age Related Macular Degeneration Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Age Related Macular Degeneration Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Age Related Macular Degeneration Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Age Related Macular Degeneration Drug Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Age Related Macular Degeneration Drug Consumption 2014-2024
- 2.1.2 Age Related Macular Degeneration Drug Consumption CAGR by Region
- 2.2 Age Related Macular Degeneration Drug Segment by Type
- 2.2.1 Lucentis
- 2.2.2 Eylea
- 2.2.3 Avastin
- 2.2.4 Other
- 2.3 Age Related Macular Degeneration Drug Consumption by Type
- 2.3.1 Global Age Related Macular Degeneration Drug Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Age Related Macular Degeneration Drug Sale Price by Type (2014-2019)
- 2.4 Age Related Macular Degeneration Drug Segment by Application
- 2.4.1 Hospitals
- 2.4.2 Clinics
- 2.4.3 Other
- 2.5 Age Related Macular Degeneration Drug Consumption by Application
- 2.5.1 Global Age Related Macular Degeneration Drug Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Age Related Macular Degeneration Drug Value and Market Share by Application (2014-2019)
- 2.5.3 Global Age Related Macular Degeneration Drug Sale Price by Application (2014-2019)
3 Global Age Related Macular Degeneration Drug by Players
- 3.1 Global Age Related Macular Degeneration Drug Sales Market Share by Players
- 3.1.1 Global Age Related Macular Degeneration Drug Sales by Players (2017-2019)
- 3.1.2 Global Age Related Macular Degeneration Drug Sales Market Share by Players (2017-2019)
- 3.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Players
- 3.2.1 Global Age Related Macular Degeneration Drug Revenue by Players (2017-2019)
- 3.2.2 Global Age Related Macular Degeneration Drug Revenue Market Share by Players (2017-2019)
- 3.3 Global Age Related Macular Degeneration Drug Sale Price by Players
- 3.4 Global Age Related Macular Degeneration Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Age Related Macular Degeneration Drug Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Age Related Macular Degeneration Drug Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Age Related Macular Degeneration Drug by Regions
- 4.1 Age Related Macular Degeneration Drug by Regions
- 4.1.1 Global Age Related Macular Degeneration Drug Consumption by Regions
- 4.1.2 Global Age Related Macular Degeneration Drug Value by Regions
- 4.2 Americas Age Related Macular Degeneration Drug Consumption Growth
- 4.3 APAC Age Related Macular Degeneration Drug Consumption Growth
- 4.4 Europe Age Related Macular Degeneration Drug Consumption Growth
- 4.5 Middle East & Africa Age Related Macular Degeneration Drug Consumption Growth
5 Americas
- 5.1 Americas Age Related Macular Degeneration Drug Consumption by Countries
- 5.1.1 Americas Age Related Macular Degeneration Drug Consumption by Countries (2014-2019)
- 5.1.2 Americas Age Related Macular Degeneration Drug Value by Countries (2014-2019)
- 5.2 Americas Age Related Macular Degeneration Drug Consumption by Type
- 5.3 Americas Age Related Macular Degeneration Drug Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Age Related Macular Degeneration Drug Consumption by Countries
- 6.1.1 APAC Age Related Macular Degeneration Drug Consumption by Countries (2014-2019)
- 6.1.2 APAC Age Related Macular Degeneration Drug Value by Countries (2014-2019)
- 6.2 APAC Age Related Macular Degeneration Drug Consumption by Type
- 6.3 APAC Age Related Macular Degeneration Drug Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Age Related Macular Degeneration Drug by Countries
- 7.1.1 Europe Age Related Macular Degeneration Drug Consumption by Countries (2014-2019)
- 7.1.2 Europe Age Related Macular Degeneration Drug Value by Countries (2014-2019)
- 7.2 Europe Age Related Macular Degeneration Drug Consumption by Type
- 7.3 Europe Age Related Macular Degeneration Drug Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Age Related Macular Degeneration Drug by Countries
- 8.1.1 Middle East & Africa Age Related Macular Degeneration Drug Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Age Related Macular Degeneration Drug Value by Countries (2014-2019)
- 8.2 Middle East & Africa Age Related Macular Degeneration Drug Consumption by Type
- 8.3 Middle East & Africa Age Related Macular Degeneration Drug Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Age Related Macular Degeneration Drug Distributors
- 10.3 Age Related Macular Degeneration Drug Customer
11 Global Age Related Macular Degeneration Drug Market Forecast
- 11.1 Global Age Related Macular Degeneration Drug Consumption Forecast (2019-2024)
- 11.2 Global Age Related Macular Degeneration Drug Forecast by Regions
- 11.2.1 Global Age Related Macular Degeneration Drug Forecast by Regions (2019-2024)
- 11.2.2 Global Age Related Macular Degeneration Drug Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Age Related Macular Degeneration Drug Forecast by Type
- 11.8 Global Age Related Macular Degeneration Drug Forecast by Application
12 Key Players Analysis
- 12.1 Regeneron Pharmaceuticals
- 12.1.1 Company Details
- 12.1.2 Age Related Macular Degeneration Drug Product Offered
- 12.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Regeneron Pharmaceuticals News
- 12.2 Bayer HealthCare
- 12.2.1 Company Details
- 12.2.2 Age Related Macular Degeneration Drug Product Offered
- 12.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Bayer HealthCare News
- 12.3 Novartis
- 12.3.1 Company Details
- 12.3.2 Age Related Macular Degeneration Drug Product Offered
- 12.3.3 Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Novartis News
- 12.4 Roche
- 12.4.1 Company Details
- 12.4.2 Age Related Macular Degeneration Drug Product Offered
- 12.4.3 Roche Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Roche News
- 12.5 Kanghong Pharma
- 12.5.1 Company Details
- 12.5.2 Age Related Macular Degeneration Drug Product Offered
- 12.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Kanghong Pharma News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Age Related Macular Degeneration Drug . Industry analysis & Market Report on Age Related Macular Degeneration Drug is a syndicated market report, published as Global Age Related Macular Degeneration Drug Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Age Related Macular Degeneration Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
